Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185952 · ClinicalTrials.gov registry record · NA
Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
A NA study of Venous Thrombosis and Obstetric Labor, Premature, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT00185952 is a NA study of Venous Thrombosis and Obstetric Labor, Premature that has completed, run by Stanford University. The registered enrollment target is 70 participants, below the 1,117-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00185952, a NA study of Venous Thrombosis and Obstetric Labor, Premature, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparing nifedipine to placebo for the maintenance tocolysis of preterm labor
Conditions Studied
Interventions
- DRUG Nifedipine
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2001-11 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185952
The ClinicalTrials.gov registry entry for NCT00185952 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,117-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (94% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Venous Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Nifedipine is the first listed.
NCT00185952 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00185952 about?
NCT00185952 is a clinical study titled "Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.". Comparing nifedipine to placebo for the maintenance tocolysis of preterm labor
What is the current status of trial NCT00185952?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2001-11. Estimated completion is 2008-08.
What conditions does trial NCT00185952 study?
This clinical trial studies the following conditions: Venous Thrombosis, Obstetric Labor, Premature.
What interventions are being tested in trial NCT00185952?
The interventions under investigation include: Nifedipine (DRUG).
Who is sponsoring clinical trial NCT00185952?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00185952 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters
COMPLETED · NA
-
Vasculaire Compression System Increases Flow Velocity in the Femoral Vein
COMPLETED · NA
-
JETi Lower Extremity Venous Thrombosis
ACTIVE NOT RECRUITING
-
Registry of AngioJet Use in the Peripheral Vascular System
COMPLETED
-
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
-
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.